Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with

M A Abrera-Abeleda1, C Nishimura, J L H Smith

  • 1Department of Otolaryngology, Division of Nephrology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Journal of Medical Genetics
|November 22, 2005
PubMed

Insights

Genetic variations in complement factor H (CFH) and CFHR5 are linked to membranoproliferative glomerulonephritis type II (MPGN II/DDD). Further studies are needed to confirm if these CFH and CFHR5 allele variants directly cause MPGN II/DDD.

Area of Science:

  • Nephrology
  • Genetics
  • Immunology

Background:

  • Membranoproliferative glomerulonephritis type II (MPGN II/DDD) leads to chronic kidney disease and end-stage renal disease.
  • Deficiencies and mutations in the complement factor H (CFH) gene are linked to MPGN II/DDD, suggesting complement dysregulation in its development.

Purpose of the Study:

  • To investigate if specific allele variants of CFH and CFHR5 are preferentially associated with the MPGN II/DDD disease phenotype.
  • To explore the role of complement system dysregulation in MPGN II/DDD pathogenesis.

Main Methods:

  • Genotyping of CFH and CFHR5 single nucleotide polymorphisms (SNPs) in MPGN II/DDD patients.
  • Comparison of allele frequencies between 131 MPGN II/DDD patients and a control group without age-related macular degeneration.

Main Results:

  • Significant differences in allele frequencies were observed for four SNPs in CFH and three SNPs in CFHR5 between MPGN II/DDD patients and controls.
  • Specific allele variants of CFH and CFHR5 were identified as potentially associated with the MPGN II/DDD phenotype.

Conclusions:

  • The study identified specific allele variants of CFH and CFHR5 associated with MPGN II/DDD.
  • While these findings suggest a role for complement in MPGN II/DDD pathogenesis, functional studies are necessary to confirm the causal relationship.
  • The identified associations may or may not be directly related to the disease's pathophysiology.
Abstract

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...